efficacy of glp 1 receptor agonists Clinical results from clinical trials comparing different Efficacy of GLP‐1 receptor agonists

3d, e and Supplementary Movie 4)

Clinical trials have demonstrated a mean weight loss of approximately 15% of initial body weight over 68 weeks when combined with lifestyle changes

The review characterizes GHK-Cu as a broad-spectrum regenerative signal that modulates thousands of genes relevant to wound healing and anti-aging, providing the genomic basis for its observed clinical effects

Stamler J, Wentworth D, Neaton JD

M.LupiL.ZacconeG.ItaliaL.RaffoM.TomasoniD.et al

"As conversations around longevity, preventative wellness, and performance continue to evolve, we're seeing growing demand for science-backed solutions that fit seamlessly into everyday life